knowledge -WSS

knowledge

author：knowledge 2025-09-27 17:02:13 - browse：287

Bernard Moss, a research scientist at NIAID. -- Infectious disease coverage from STAT — Bernard Moss Courtesy NIAID

For more than half a century, scientist Bernard Moss has been commanding the attention of peers interested in prying biological secrets from poxviruses and other microbiological targets. Now he’s commanding the attention of a different audience: House Republicans.

Moss, who will mark his 86th birthday in late July and who goes by Bernie, has worked for more than 55 years in the laboratories of the National Institute of Allergy and Infectious Diseases in Bethesda, Md. Over that time, he has been investigating viruses in relative anonymity — except, that is, among the virological cognoscenti.

But last year, in an interview with Science, Moss said he planned to try to determine why one strain of mpox viruses, known as Clade 1, is so much more virulent than those in a second strain, Clade 2, by taking genes from the former and putting them into the latter. Clade 2 viruses are responsible for the ongoing mpox outbreak first detected in May 2022.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： 340B reform proposal comes out of Senate working group

WSS

Why Novartis is going to walk from its acquisition of MorphoSys

Readout Newsletter: Amgen, Regeneron, BGI Group and more

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

Why Novartis is going to walk from its acquisition of MorphoSys

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

Cano Health’s bankruptcy is a warning for Medicare Advantage

focus

knowledge

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Caribou posts encouraging results on off

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

The high cost of giving birth even with insurance

'CMA Fest' 2023: How to watch, who is performing and more

Sports medicine is finally prioritizing gender equality

Bernie brings in new pharma CEOs to talk drug prices

Novavax promises a turnaround & Lilly roils the obesity market

AstraZeneca stays mum on Medicare drug pricing negotiations

focus

A protest over insulin prices is seen as a fight for life

Texas Medical Board asked to define abortion emergency exception

There’s a way to spot data fakery. All journals should be using it

Cano Health’s bankruptcy is a warning for Medicare Advantage

Why CTE doesn’t keep Americans from enjoying the Super Bowl

When a patient nears the end, a feared therapy can comfort

focus

explore

knowledge

leisure time